OF
Oxford Finance LLC
Private EquityActiveOxford Finance delivers flexible financial solutions to healthcare and life sciences companies worldwide.
100
Investments
9
Exits
$11B
AUM
9.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Oxford Finance LLC.
Investment Thesis & Strategy
Oxford Finance invests in various stages of fintech and life science companies, providing flexible financial solutions to companies worldwide.
Investment Activity
Deals per year over the last 9 years
1
20102
20110
20122
20132
20141
20150
20163
20171
2018Portfolio Companies
Selected investments from their portfolio of 100 companies
X
Xeris Biopharma
Biotech · Growth, 2018
B
Biohaven Pharmaceutical
Biotech · Growth, 2017
A
Apellis Pharmaceuticals
Biotech · Growth, 2017
O
ObsEva
Biotech · Growth, 2017
A
ANI Pharmaceuticals
Biotech · Growth, 2015
C
Collegium Pharmaceutical
Biotech · Growth, 2014
A
Aerie Pharmaceuticals
Biotech · Growth, 2014
C
Catalent
Healthcare · Growth, 2013
P
Portola Pharmaceuticals
Biotech · Growth, 2013
P
Pacira BioSciences
Biotech · Growth, 2011
I
Intercept Pharmaceuticals
Biotech · Growth, 2011
A
Acadia Pharmaceuticals
Biotech · Growth, 2010
Notable Exits
CompanyTypeYearValue / Acquirer
Achieve Life SciencesIPO2024—
Obsidian TherapeuticsIPO2024—
Ventyx BiosciencesIPO2022—
Turning Point TherapeuticsAcquisition2022$4.1B
Revolution MedicinesIPO2020—
Aprea TherapeuticsIPO2020—
Portola PharmaceuticalsAcquisition2020$1.4B
ARMO BioSciencesAcquisition2018$1.6B
Kura OncologyIPO2014—
Frequently Asked Questions
Oxford Finance LLC focuses on Series B, Series C+ stage investments.
Related Investors
Telcom Ventures
Alexandria, United States · 12 deals
DC Capital Partners
Alexandria, United States · 4 deals
Piranha Tank
Alexandria, United States · 0 deals
1839 Capital
Alexandria, United States · 0 deals
Savoia Capital Partners I, LLC
Alexandria, United States · 0 deals
3i Group
London, United Kingdom · 455 deals